|Bid||1.8000 x 47300|
|Ask||1.8100 x 3000|
|Day's range||1.7000 - 1.8400|
|52-week range||0.1500 - 3.4500|
|Beta (5Y monthly)||3.30|
|PE ratio (TTM)||N/A|
|Earnings date||05 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.25|
At the close of trading on Wall Street Tuesday, MicroVision shares were up by 27%. On Monday, SeekingAlpha contributor "White Diamond Research" made the case that MicroVision, a stock that has surged from less than $0.20 a share to more than $2.50 a share in just the past four months, is actually worth less than the $0.20 it used to cost. In fact, argued White Diamond, MicroVision's scanning technology is worth "very little," and its stock could be either worth $0.15 a share ... or even be "completely worthless."
MicroVision (MVIS) closed the most recent trading day at $2.02, moving -0.98% from the previous trading session.
Shares of scanning technology-maker MicroVision (NASDAQ: MVIS) took a tumble on Tuesday, falling 10% in response to a negative note from Wolfpack Research, which blasted the company's "ridiculous" valuation, and said stock traders' decision to bid the company up 1,000% in three months in hopes of profiting from "a $1 billion buyout ... have absolutely no basis in reality." MicroVision's fans didn't like hearing that one bit, and in fairly short order, a Twitter war flared up with the company's supporters leaping to its defense, while detractors (Wolfpack being chief among them) insisted momentum traders are "out of [their] league on this one." MicroVision shares rallied with their defenders, gaining 5.1% yesterday -- about half what they had lost on the short report.